title: Atypical lentigines in a man with mixed African American and white race/ethnicity receiving long-term voriconazole therapy.
authors.affiliation: Perelman School of Medicine, Philadelphia, Pennsylvania.
authors.forename: Paul R
authors.initials: PR
authors.lastname: Massey
authors.affiliation: Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia.
authors.forename: Karolyn A
authors.initials: KA
authors.lastname: Wanat
authors.affiliation: Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia.
authors.forename: Rosalie
authors.initials: R
authors.lastname: Elenitsas
authors.affiliation: Department of Dermatology, University of Pennsylvania, Philadelphia.
authors.forename: Misha
authors.initials: M
authors.lastname: Rosenbach
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D001741:Black or African American; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use; D003881:Dermatomycoses / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D007911:Lentigo / Q000139:chemically induced* / Q000473:pathology*; D008297:Male; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D017565:Sarcoidosis, Pulmonary / Q000175:diagnosis / Q000188:drug therapy; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use; D065819:Voriconazole; D044465:White People
chemical_list: D000305:Adrenal Cortex Hormones; D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole